BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15316900)

  • 1. Young age and outcome for women with early-stage invasive breast carcinoma.
    Zhou P; Recht A
    Cancer; 2004 Sep; 101(6):1264-74. PubMed ID: 15316900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving local control with breast-conserving therapy: a 27-year single-institution experience.
    Cabioglu N; Hunt KK; Buchholz TA; Mirza N; Singletary SE; Kuerer HM; Babiera GV; Ames FC; Sahin AA; Meric-Bernstam F
    Cancer; 2005 Jul; 104(1):20-9. PubMed ID: 15912514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
    Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is mastectomy superior to breast-conserving treatment for young women?
    Coulombe G; Tyldesley S; Speers C; Paltiel C; Aquino-Parsons C; Bernstein V; Truong PT; Keyes M; Olivotto IA
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1282-90. PubMed ID: 17275207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of breast-conserving therapy versus radical mastectomy on prognosis for young women with breast carcinoma.
    Kroman N; Holtveg H; Wohlfahrt J; Jensen MB; Mouridsen HT; Blichert-Toft M; Melbye M
    Cancer; 2004 Feb; 100(4):688-93. PubMed ID: 14770422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast-conserving therapy in young women with invasive carcinoma of the breast.
    Borg MF
    Australas Radiol; 2004 Sep; 48(3):376-82. PubMed ID: 15344990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome after selective treatment of patients diagnosed with ductal carcinoma in situ of the breast.
    Meijnen P; Oldenburg HS; Peterse JL; Bartelink H; Rutgers EJ
    Ann Surg Oncol; 2008 Jan; 15(1):235-43. PubMed ID: 17987342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
    Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting outcome for young women with early stage invasive breast cancer treated with breast-conserving therapy.
    Zhou P; Gautam S; Recht A
    Breast Cancer Res Treat; 2007 Jan; 101(1):51-7. PubMed ID: 16821084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognosis of patients with local recurrence more than five years after breast conservation therapy for invasive breast carcinoma.
    van der Sangen MJ; van de Poll-Franse LV; Roumen RM; Rutten HJ; Coebergh JW; Vreugdenhil G; Voogd AC
    Eur J Surg Oncol; 2006 Feb; 32(1):34-8. PubMed ID: 16305821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuing risk of ipsilateral breast relapse after breast-conserving therapy at long-term follow-up.
    Kreike B; Hart AA; van de Velde T; Borger J; Peterse H; Rutgers E; Bartelink H; van de Vijver MJ
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1014-21. PubMed ID: 18234444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of lobular carcinoma in situ in association with invasive breast cancer on the rate of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy.
    Jolly S; Kestin LL; Goldstein NS; Vicini FA
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):365-71. PubMed ID: 16965988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes in patients with mucinous, medullary, tubular, and invasive ductal carcinomas after lumpectomy.
    Vo T; Xing Y; Meric-Bernstam F; Mirza N; Vlastos G; Symmans WF; Perkins GH; Buchholz TA; Babiera GV; Kuerer HM; Bedrosian I; Akins JS; Hunt KK
    Am J Surg; 2007 Oct; 194(4):527-31. PubMed ID: 17826073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases.
    Komoike Y; Akiyama F; Iino Y; Ikeda T; Akashi-Tanaka S; Ohsumi S; Kusama M; Sano M; Shin E; Suemasu K; Sonoo H; Taguchi T; Nishi T; Nishimura R; Haga S; Mise K; Kinoshita T; Murakami S; Yoshimoto M; Tsukuma H; Inaji H
    Cancer; 2006 Jan; 106(1):35-41. PubMed ID: 16333848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors that influence surgical choices in women with breast carcinoma.
    Staradub VL; Hsieh YC; Clauson J; Langerman A; Rademaker AW; Morrow M
    Cancer; 2002 Sep; 95(6):1185-90. PubMed ID: 12216083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma.
    Vo TN; Meric-Bernstam F; Yi M; Buchholz TA; Ames FC; Kuerer HM; Bedrosian I; Hunt KK
    Am J Surg; 2006 Oct; 192(4):552-5. PubMed ID: 16978974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.
    Sahoo S; Recant WM; Jaskowiak N; Tong L; Heimann R
    Breast J; 2005; 11(4):242-7. PubMed ID: 15982389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant increase in breast conservation in 16 years of trials conducted by the Austrian Breast & Colorectal Cancer Study Group.
    Jakesz R; Samonigg H; Gnant M; Kubista E; Depisch D; Kolb R; Mlineritsch B; Mischinger HJ; Menzel RC; Steindorfer P; Kwasny W; Tausch C; Stierer M; Taucher S; Seifert M; Hausmaninger H;
    Ann Surg; 2003 Apr; 237(4):556-64. PubMed ID: 12677153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes after breast conservation therapy for early stage breast cancer in a community setting.
    McCloskey SA; Botnick LE; Rose CM; Malcolm AW; Ozohan ML; Mena R; Llamas L; Tao ML
    Breast J; 2006; 12(2):138-44. PubMed ID: 16509838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appropriateness of breast-conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2: a clinic-based series.
    Robson M; Svahn T; McCormick B; Borgen P; Hudis CA; Norton L; Offit K
    Cancer; 2005 Jan; 103(1):44-51. PubMed ID: 15558796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.